Could Inflammaging and Its Sequelae Be Prevented or Mitigated?

Mao-Qiang Man,1,2 Peter M Elias2 1Dermatology Hospital of Southern Medical University, Guangzhou 510091, People’s Republic of China; 2Dermatology Services, Veterans Affairs Medical Center, University of California San Francisco, San Francisco, CA 94121, USACorrespondence: Mao-Qiang ManDerm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Man MQ, Elias PM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/5ad395c9c94b4391bf1888e9cf0f8d9a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5ad395c9c94b4391bf1888e9cf0f8d9a
record_format dspace
spelling oai:doaj.org-article:5ad395c9c94b4391bf1888e9cf0f8d9a2021-12-02T08:04:07ZCould Inflammaging and Its Sequelae Be Prevented or Mitigated?1178-1998https://doaj.org/article/5ad395c9c94b4391bf1888e9cf0f8d9a2019-12-01T00:00:00Zhttps://www.dovepress.com/could-inflammaging-and-its-sequelae-be-prevented-or-mitigated-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Mao-Qiang Man,1,2 Peter M Elias2 1Dermatology Hospital of Southern Medical University, Guangzhou 510091, People’s Republic of China; 2Dermatology Services, Veterans Affairs Medical Center, University of California San Francisco, San Francisco, CA 94121, USACorrespondence: Mao-Qiang ManDermatology Service (190), 4150 Clement Street, San Francisco, CA 94121, USATel +1 415 575-0539Fax +1 415 750-2106Email mqman@hotmail.comAbstract: Aged humans display a chronic and low-grade inflammation, termed “inflammaging”, which has been potentially linked to the subsequent development of some aging-associated systemic disorders, including type 2 diabetes, atherosclerotic cardiovascular disease, Alzheimer’s disease and obesity. Though the origin of aging-associated systemic inflammation is uncertain, epidemiological studies show that inflammatory dermatoses (psoriasis and eczema) are risk factors for some aging-associated systemic disorders, such as type 2 diabetes and atherosclerotic cardiovascular disease. Moreover, recent studies demonstrate that epidermal dysfunction in aged skin not only causes cutaneous inflammation, but also a subsequent increase in circulating levels of proinflammatory cytokines, suggesting that the skin could be a major contributor to inflammaging. This hypothesis is further supported by reductions in circulating levels of proinflammatory cytokines in both aged humans and murine, following improvements in epidermal function with topical emollients. Therefore, correction of epidermal dysfunction could be a novel approach for the prevention and mitigation of certain inflammation-associated chronic disorders in aged humans.Keywords: aging, inflammation, inflammaging, epidermis, systemic disordersMan MQElias PMDove Medical Pressarticleaginginflammationinflammagingepidermissystemic disordersGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 14, Pp 2301-2304 (2019)
institution DOAJ
collection DOAJ
language EN
topic aging
inflammation
inflammaging
epidermis
systemic disorders
Geriatrics
RC952-954.6
spellingShingle aging
inflammation
inflammaging
epidermis
systemic disorders
Geriatrics
RC952-954.6
Man MQ
Elias PM
Could Inflammaging and Its Sequelae Be Prevented or Mitigated?
description Mao-Qiang Man,1,2 Peter M Elias2 1Dermatology Hospital of Southern Medical University, Guangzhou 510091, People’s Republic of China; 2Dermatology Services, Veterans Affairs Medical Center, University of California San Francisco, San Francisco, CA 94121, USACorrespondence: Mao-Qiang ManDermatology Service (190), 4150 Clement Street, San Francisco, CA 94121, USATel +1 415 575-0539Fax +1 415 750-2106Email mqman@hotmail.comAbstract: Aged humans display a chronic and low-grade inflammation, termed “inflammaging”, which has been potentially linked to the subsequent development of some aging-associated systemic disorders, including type 2 diabetes, atherosclerotic cardiovascular disease, Alzheimer’s disease and obesity. Though the origin of aging-associated systemic inflammation is uncertain, epidemiological studies show that inflammatory dermatoses (psoriasis and eczema) are risk factors for some aging-associated systemic disorders, such as type 2 diabetes and atherosclerotic cardiovascular disease. Moreover, recent studies demonstrate that epidermal dysfunction in aged skin not only causes cutaneous inflammation, but also a subsequent increase in circulating levels of proinflammatory cytokines, suggesting that the skin could be a major contributor to inflammaging. This hypothesis is further supported by reductions in circulating levels of proinflammatory cytokines in both aged humans and murine, following improvements in epidermal function with topical emollients. Therefore, correction of epidermal dysfunction could be a novel approach for the prevention and mitigation of certain inflammation-associated chronic disorders in aged humans.Keywords: aging, inflammation, inflammaging, epidermis, systemic disorders
format article
author Man MQ
Elias PM
author_facet Man MQ
Elias PM
author_sort Man MQ
title Could Inflammaging and Its Sequelae Be Prevented or Mitigated?
title_short Could Inflammaging and Its Sequelae Be Prevented or Mitigated?
title_full Could Inflammaging and Its Sequelae Be Prevented or Mitigated?
title_fullStr Could Inflammaging and Its Sequelae Be Prevented or Mitigated?
title_full_unstemmed Could Inflammaging and Its Sequelae Be Prevented or Mitigated?
title_sort could inflammaging and its sequelae be prevented or mitigated?
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/5ad395c9c94b4391bf1888e9cf0f8d9a
work_keys_str_mv AT manmq couldinflammaginganditssequelaebepreventedormitigated
AT eliaspm couldinflammaginganditssequelaebepreventedormitigated
_version_ 1718398662949732352